The Filings Report

Globe Life Inc.

GLNYSECIK 320335Financial / Insurance - Lifefiscal year ends December72 quarters since 2008

Revenue, Q2 FY2026
$1.6B
+8.0% on Q2 FY2025
Net income
$288M
+13.8% on Q2 FY2025
Free cash flow
$298M
+0.9% on Q2 FY2025
Diluted EPS
$3.65
+19.7% on Q2 FY2025
Revenue, TTM
$6.2B
trailing four quarters
Net margin, TTM
19.6%
net income $1.2B
Free cash flow, TTM
$1.2B
$1.4B less $159M capex
Cash and equivalents
—
long-term debt $2.7B, Jun 30, 2026
Shares, 12-month change
−5.1%
77M shares, Jun 30, 2026
Buybacks, TTM
$881M
7.2% of market value
Dividends, TTM
$91M
0.7% of market value
Market value
$12.3B
at the close, buybacks

Latest quarter Q2 FY2026, filed August 5, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, Globe Life Inc. reported revenue of $1.6B, +8.0% on Q2 FY2025, and net income of $288M (+13.8%). Free cash flow, operating cash flow less capital expenditures, was $298M ($314M less $16M). Diluted earnings per share were $3.65.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of August 5, 2026.

Revenue and net incomeRevenueNet income
$0$500M$1.0B$1.5B$2.0BQ3'22, Revenue: $1.3BQ3'22, Net income: $191MQ3'22Q4'22, Revenue: $1.3BQ4'22, Net income: $242MQ4'22Q1'23, Revenue: $1.3BQ1'23, Net income: $224MQ1'23Q2'23, Revenue: $1.3BQ2'23, Net income: $215MQ2'23Q3'23, Revenue: $1.4BQ3'23, Net income: $257MQ3'23Q4'23, Revenue: $1.4BQ4'23, Net income: $275MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $254MQ1'24Q2'24, Revenue: $1.4BQ2'24, Net income: $258MQ2'24Q3'24, Revenue: $1.5BQ3'24, Net income: $303MQ3'24Q4'24, Revenue: $1.5BQ4'24, Net income: $255MQ4'24Q1'25, Revenue: $1.5BQ1'25, Net income: $255MQ1'25Q2'25, Revenue: $1.5BQ2'25, Net income: $253MQ2'25Q3'25, Revenue: $1.5BQ3'25, Net income: $388MQ3'25Q4'25, Revenue: $1.5BQ4'25, Net income: $266MQ4'25Q1'26, Revenue: $1.6BQ1'26, Net income: $271MQ1'26Q2'26, Revenue: $1.6BQ2'26, Net income: $288MQ2'26$0$500M$1.0B$1.5B$2.0BQ3'22, Revenue: $1.3BQ3'22, Net income: $191MQ4'22, Revenue: $1.3BQ4'22, Net income: $242MQ4'22Q1'23, Revenue: $1.3BQ1'23, Net income: $224MQ2'23, Revenue: $1.3BQ2'23, Net income: $215MQ2'23Q3'23, Revenue: $1.4BQ3'23, Net income: $257MQ4'23, Revenue: $1.4BQ4'23, Net income: $275MQ4'23Q1'24, Revenue: $1.4BQ1'24, Net income: $254MQ2'24, Revenue: $1.4BQ2'24, Net income: $258MQ2'24Q3'24, Revenue: $1.5BQ3'24, Net income: $303MQ4'24, Revenue: $1.5BQ4'24, Net income: $255MQ4'24Q1'25, Revenue: $1.5BQ1'25, Net income: $255MQ2'25, Revenue: $1.5BQ2'25, Net income: $253MQ2'25Q3'25, Revenue: $1.5BQ3'25, Net income: $388MQ4'25, Revenue: $1.5BQ4'25, Net income: $266MQ4'25Q1'26, Revenue: $1.6BQ1'26, Net income: $271MQ2'26, Revenue: $1.6BQ2'26, Net income: $288MQ2'26

Net income losses drawn in red.

Free cash flow
$0$200M$400M$600MQ3'22, Free cash flow: $351MQ3'22Q4'22, Free cash flow: $364MQ4'22Q1'23, Free cash flow: $469MQ1'23Q2'23, Free cash flow: $309MQ2'23Q3'23, Free cash flow: $276MQ3'23Q4'23, Free cash flow: $378MQ4'23Q1'24, Free cash flow: $342MQ1'24Q2'24, Free cash flow: $356MQ2'24Q3'24, Free cash flow: $311MQ3'24Q4'24, Free cash flow: $322MQ4'24Q1'25, Free cash flow: $420MQ1'25Q2'25, Free cash flow: $295MQ2'25Q3'25, Free cash flow: $209MQ3'25Q4'25, Free cash flow: $330MQ4'25Q1'26, Free cash flow: $396MQ1'26Q2'26, Free cash flow: $298MQ2'26$0$200M$400M$600MQ3'22, Free cash flow: $351MQ4'22, Free cash flow: $364MQ4'22Q1'23, Free cash flow: $469MQ2'23, Free cash flow: $309MQ2'23Q3'23, Free cash flow: $276MQ4'23, Free cash flow: $378MQ4'23Q1'24, Free cash flow: $342MQ2'24, Free cash flow: $356MQ2'24Q3'24, Free cash flow: $311MQ4'24, Free cash flow: $322MQ4'24Q1'25, Free cash flow: $420MQ2'25, Free cash flow: $295MQ2'25Q3'25, Free cash flow: $209MQ4'25, Free cash flow: $330MQ4'25Q1'26, Free cash flow: $396MQ2'26, Free cash flow: $298MQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$1B$2B$3BQ3'22, Long-term debt: $1.6BQ3'22Q4'22, Long-term debt: $1.6BQ4'22Q1'23, Long-term debt: $1.6BQ1'23Q2'23, Long-term debt: $1.8BQ2'23Q3'23, Long-term debt: $1.8BQ3'23Q4'23, Long-term debt: $1.6BQ4'23Q1'24, Long-term debt: $1.6BQ1'24Q2'24, Long-term debt: $1.6BQ2'24Q3'24, Long-term debt: $2.3BQ3'24Q4'24, Long-term debt: $2.3BQ4'24Q1'25, Long-term debt: $2.3BQ1'25Q2'25, Long-term debt: $2.3BQ2'25Q3'25, Long-term debt: $2.3BQ3'25Q4'25, Long-term debt: $2.3BQ4'25Q1'26, Long-term debt: $2.3BQ1'26Q2'26, Long-term debt: $2.7BQ2'26$0$1B$2B$3BQ3'22, Long-term debt: $1.6BQ4'22, Long-term debt: $1.6BQ4'22Q1'23, Long-term debt: $1.6BQ2'23, Long-term debt: $1.8BQ2'23Q3'23, Long-term debt: $1.8BQ4'23, Long-term debt: $1.6BQ4'23Q1'24, Long-term debt: $1.6BQ2'24, Long-term debt: $1.6BQ2'24Q3'24, Long-term debt: $2.3BQ4'24, Long-term debt: $2.3BQ4'24Q1'25, Long-term debt: $2.3BQ2'25, Long-term debt: $2.3BQ2'25Q3'25, Long-term debt: $2.3BQ4'25, Long-term debt: $2.3BQ4'25Q1'26, Long-term debt: $2.3BQ2'26, Long-term debt: $2.7BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 5, 2026.

Globe Life Inc. income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 6, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 26, 2025Q3 FY2024ended Sep 30, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue1,6001,5601,5201,5131,4811,4801,4661,455+8.0%
Cost of revenue—————————
Gross profit———————379—
Research and development—————————
Selling, general and administrative———————89—
Operating income———————383—
Other income (expense)00(2)0—00(1)—
Pretax income355334329477313316312377+13.3%
Income tax6764638961625774+10.9%
Net income288271266388253255255303+13.8%
Diluted EPS ($)3.653.39—4.733.053.01—3.44+19.7%
Diluted shares (millions)7980—828384—88—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 5, 2026.

Globe Life Inc. balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 6, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 26, 2025Q3 FY2024ended Sep 30, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents—————————
Short-term investments1981843156311713485101+69.9%
Total current assets—————————
Total assets31,56330,96630,81430,52829,80929,70529,07629,557+5.9%
Total current liabilities—————————
Long-term debt2,6652,3222,3212,3202,3262,3252,3242,324+14.6%
Total liabilities25,40724,88124,83924,83924,39024,28023,77124,918+4.2%
Stockholders’ equity6,1566,0855,9755,6895,4195,4255,3064,639+13.6%
Shares outstanding (millions)7778798081838484—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 5, 2026.

Globe Life Inc. cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 6, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 26, 2025Q3 FY2024ended Sep 30, 2024filed Nov 6, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow314421351306308432337341+2.0%
Capital expenditures1625219713121529+27.5%
Free cash flow (CFO − capex)298396330209295420322311+0.9%
Depreciation and amortization—————————
Share repurchases27524019217425026552591+9.8%
Dividends paid2621222222202022+14.8%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 25, 2026.

Income statement

Globe Life Inc. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 26, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 23, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 25, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Mar 1, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 27, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 28, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Aug 7, 2009FY2007ended Dec 31, 2007filed Aug 7, 2009
Revenue5,9945,7785,4485,2275,1124,7384,5284,3044,1563,9353,7663,6203,4943,5903,3773,3683,1153,1963,487
Cost of revenue———————————————————
Gross profit——1,2601,1791,215901911865807783775761747728698713707——
Research and development———————————————————
Selling, general and administrative——302308282255249228211197186177177165179156151——
Operating income——1,2651,1861,227905920871821787776772756754732722707——
Other income (expense)(2)(3)(4)5124951441119320—0——
Pretax income1,4361,3271,1941,1021,275897931864831772766785755766724751577628797
Income tax275256224208243165170162(628)233250257248237226246191199269
Net income1,1611,0719718941,0317327617011,454550527543528529497499405452528
Diluted EPS ($)14.0711.9410.079.049.996.826.836.0912.224.494.164.093.793.603.02*2.70*2.17*2.27*2.44*
Diluted shares (millions)83909699103107111115119122127133140147165*185*187*——

Balance sheet

Globe Life Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 26, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 23, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 25, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Mar 1, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 27, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 28, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Aug 7, 2009FY2007ended Dec 31, 2007filed Aug 7, 2009
Cash and equivalents—————————————62843662324620
Short-term investments315858211469108386312772551677——————
Total current assets———————————————————
Total assets30,81429,07628,05125,98729,76829,04725,97723,09623,47521,43619,85320,27218,19218,77716,58816,16016,02413,529—
Total current liabilities———————————————————
Long-term debt2,3212,3241,6301,6281,5461,6681,3491,3571,1321,133744992991990791790796499—
Total liabilities24,83923,77123,56522,03721,12520,27618,68317,68117,24416,86915,79815,57514,41514,41512,72912,14412,62511,306—
Stockholders’ equity5,9755,3064,4873,9502,0049347,2945,4156,2314,5674,0564,6973,7764,3623,8603,6673,0682,2233,325
Shares outstanding (millions)7984949699103108110114118121127133*140*150*175*186*——

Cash flow statement

Globe Life Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 26, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 23, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 25, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Mar 1, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 27, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 28, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Aug 7, 2009FY2007ended Dec 31, 2007filed Aug 7, 2009
Operating cash flow1,3961,4021,4821,4221,4381,4761,3641,2781,4291,3991,1208651,1199438591,029976731850
Capital expenditures14271502838424245202537191155961024
Free cash flow (CFO − capex)1,2541,3311,4331,3941,3991,4351,3221,2331,4091,3741,0838451,1089388541,019970721826
Depreciation and amortization———————————————————
Share repurchases8811,00251145554144446042241340541944948257097324648456452
Dividends paid86858481807874716967676561564950474950

Insider activity

Form 4 filings by officers, directors and 10% owners, November 3, 2024 to November 3, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$8M
6 sales by 3 insiders; officers and directors $8M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$84M
84 sales by 12 insiders; officers and directors $84M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 23, 2026Majors Michael ClayEVP - Chief Strategy Officeropen-market sale14,377$154.48$2M39,141Oct 26, 2026
Sep 22, 2026Hensley Robert EdwardEVP & Chief Investment Officeroption exercise10,000$103.23$1M22,384Sep 23, 2026
Sep 22, 2026Hensley Robert EdwardEVP & Chief Investment Officeropen-market sale3,344$169.53$567K19,040Sep 23, 2026
Sep 22, 2026Hensley Robert EdwardEVP & Chief Investment Officeropen-market sale6,656$170.34$1M12,384Sep 23, 2026
Aug 7, 2026Mitchell Robert BrianEVP, General Counsel and CROoption exercise23,000$103.23$2M30,981Aug 10, 2026
Aug 7, 2026Mitchell Robert BrianEVP, General Counsel and CROopen-market sale11,454$182.77$2M19,527Aug 10, 2026
Aug 7, 2026Mitchell Robert BrianEVP, General Counsel and CROopen-market sale10,529$183.83$2M8,998Aug 10, 2026
Aug 7, 2026Mitchell Robert BrianEVP, General Counsel and CROopen-market sale1,017$184.75$188K7,981Aug 10, 2026
Jul 31, 2026Darden James MatthewCo-Chairman & CEO, Directoroption exercise50,000$98.32$5M108,451Aug 3, 2026
Jul 31, 2026Darden James MatthewCo-Chairman & CEO, Directoropen-market sale49,600$182.43$9M58,851Aug 3, 2026
Jul 31, 2026Darden James MatthewCo-Chairman & CEO, Directoropen-market sale400$183.36$73K58,451Aug 3, 2026
Jul 30, 2026Kalmbach Thomas PeterEVP & CFOoption exercise10,000$103.23$1M60,568Jul 30, 2026
Jul 30, 2026Kalmbach Thomas PeterEVP & CFOoption exercise11,000$120.49$1M71,568Jul 30, 2026
Jul 30, 2026Kalmbach Thomas PeterEVP & CFOopen-market sale10,720$179.30$2M60,848Jul 30, 2026
Jul 30, 2026Kalmbach Thomas PeterEVP & CFOopen-market sale4,840$180.08$872K56,008Jul 30, 2026
Jul 30, 2026Kalmbach Thomas PeterEVP & CFOopen-market sale2,650$181.23$480K53,358Jul 30, 2026
Jul 30, 2026Kalmbach Thomas PeterEVP & CFOopen-market sale2,790$181.81$507K50,568Jul 30, 2026
Jul 29, 2026Majors Michael ClayEVP - Chief Strategy Officeroption exercise37,000$103.23$4M90,518Jul 30, 2026
Jul 29, 2026Majors Michael ClayEVP - Chief Strategy Officeropen-market sale33,500$178.56$6M57,018Jul 30, 2026
Jul 29, 2026Majors Michael ClayEVP - Chief Strategy Officeropen-market sale3,500$179.35$628K53,518Jul 30, 2026
Jul 28, 2026Kalmbach Thomas PeterEVP & CFOoption exercise14,100$120.49$2M64,668Jul 29, 2026
Jul 28, 2026Kalmbach Thomas PeterEVP & CFOoption exercise11,550$128.40$1M76,218Jul 29, 2026
Jul 28, 2026Kalmbach Thomas PeterEVP & CFOopen-market sale9,550$178.06$2M66,668Jul 29, 2026
Jul 28, 2026Kalmbach Thomas PeterEVP & CFOopen-market sale12,303$178.73$2M54,365Jul 29, 2026
Jul 28, 2026Kalmbach Thomas PeterEVP & CFOopen-market sale3,797$179.42$681K50,568Jul 29, 2026

Full insider history for Globe Life Inc., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
GLOBE LIFE INC., CIK 320335 on EDGAR
Extract generated
November 4, 2026
Withheld
4 line-years whose four quarters do not sum to the filed year: net income FY2010, pretax income FY2010, revenue FY2013, revenue FY2014
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: not filed
Gross profit: GrossProfit
Research and development: not filed
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: not filed
Total assets: Assets
Total current liabilities: not filed
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: not filed
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends

The data

The statements on this page as files, generated November 4, 2026.

JSON file
/data/financials/GL.json